发明名称 Mirabegron eller salter derav - (R)-2-(2-aminotiazol-4-yl)-4'-[2-[(2-hydroksy-2-fenyletyl)amino]etyl]eddiksyreanilid eller aminotiazolacetamide (2-(2-Amino-1,3-tiazol-4-yl)-N-[4-(2-[(2R)-2-hydroksy-2 fenyletyl]aminoetyl)fenyl]acetamid) - se krav 1 i patentet
摘要 <p>(R)-2-(2-aminothiazol-4-yl)-4'-Ä2-Ä(2-hydroxy-2-phenylethyl)aminoÜethylÜacetic acid anilide or its salt shows a potent bladder relaxation effect in "isolated rat bladder smooth muscle relaxation test", dose-dependently lowers the contraction frequency of rhythmic bladder contractions in "rat rhythmic bladder contraction measurement test" and, moreover, prolongs the urination intervals in "urination functions measurement test on cyclophosphamide-induced overactive bladder model rat". Owing to these effects, the above compound is useful as a remedy for ovaractive bladder.</p>
申请公布号 NO2015001(I1) 申请公布日期 2015.01.26
申请号 NO20150000001C 申请日期 2015.01.19
申请人 发明人
分类号 A61K31/426;A61P13/00;A61P13/10;C07D277/40 主分类号 A61K31/426
代理机构 代理人
主权项
地址